Daniel A Briere Selected Research

Daniel A Briere Research Topics

8	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2005
4	Obesity 01/2022 - 12/2018
4	Body Weight (Weight, Body) 01/2022 - 09/2018
4	Weight Loss (Weight Reduction) 01/2022 - 01/2015
2	Vomiting 01/2022 - 12/2018
2	Nausea 01/2022 - 12/2018
1	Insulin Resistance 01/2021
1	Metabolic Diseases (Metabolic Disease) 09/2018

6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2005
5	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2020 - 01/2015
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 09/2018
3	tirzepatideIBA 01/2021 - 12/2018
2	Glucagon (Glukagon)FDA Link 01/2022 - 09/2018
2	Peptide YYIBA 01/2022 - 01/2015
2	compound 18IBA 07/2020 - 01/2015
1	Peptides (Polypeptides)IBA 01/2022
1	gastric inhibitory polypeptide receptorIBA 01/2022
1	retatrutideIBA 01/2022
1	Branched-Chain Amino AcidsIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	dulaglutideIBA 10/2020
1	IncretinsIBA 12/2018
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2018
1	PPAR gammaIBA 12/2006
1	Triglycerides (Triacylglycerol)IBA 01/2005

2	Glycemic Control 01/2022 - 01/2021
1	Therapeutics 01/2022
1	Gastrectomy 01/2020
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2020